AGENDA
Spring 2021 Meeting
(December 2021 Agenda to Be Announced 11/22)

MONDAY, MARCH 29, 2021

All Times are EST Time Zone
 

9:10am // OPENING REMARKS 

9:20am // KEYNOTE TALK - BIDEN'S CANCER POLICY 

                   Greg Simon (Former Executive Director Biden Cancer Initiative, Former Executive Director White House Moonshot, Former Director Domestic
                   Policy for Al Gore, Fmr  Director of Global Public Affairs for Pfizer)

9:50am // Corporate Presentation - PharmAbcine

10:10am // Corporate Presentation - Pleco Therapeutics

10:30am // Corporate Presentation - Telexos

10:50am // Corporate Presentation - Heidelberg Pharma

11:10am // Corporate Presentation - Vivan Therapeutics

11:30am // Corporate Presentation - Katena Oncology

11:50am // Corporate Presentation - Cogen Bioscience
12:10pm // Corporate Presentation - Seneca Therapeutics

12:30pm // Corporate Presentation - Immunicom

12:50pm // INVESTOR PANEL

                     Moderator: William Werkmeister (Partner, OIP | Advisory Board, NFCR)

                                          Richard Lipkin (Partner, Catalytic Impact Fund | Former Partner, Easton Capital)

                                          Anton Gopka (Partner, ATEM Capital | NCI Venture Advisory Board)

                                          Sal Buscemi (Founder, Dandrew Partners Encore Ventures FO)                                                                                    

1:20 pm // Corporate Presentation - Relevant Biosciences

1:40pm // Corporate Presentation - Actinium Pharmaceuticals (ATNM)

2:00pm // Corporate Presentation - Genprex (GNPX)

2:20pm // Corporate Presentation - SIWA Therapeutics

2:40pm // Corporate Presentation - Avidea Technologies

3:00pm // Corporate Presentation - RubrYc Therapeutics

3:20pm // Corporate Presentation - Filtricine

3:40pm // Corporate Presentation - BioEclipse Therapeutics

4:00pm // Corporate Presentation - NanoView Biosciences

4:20pm // Corporate Presentation - Ascentage Pharma

4:40pm // Corporate Presentation - Imagion Biosystems

5:00pm // TALK - NATIONAL FOUNDATION FOR CANCER RESEARCH - REVIEW OF NFCR FUNDING OPTIONS AND $1MILLION WOMEN'S VENTURE
                                COMPETITION

                                Rose Wang, Board Member of NFCR AIM-HI Women's Venture Competition

 5:30pm // CLOSING REMARKS

TUESDAY, MARCH 30, 2021

All Times are EST Time Zone

8:50am // OPENING REMARKS - COVID SESSION

9:00am // KEYNOTE TALK - THE EFFICACY OF COVID-19 VACCINES 

                   Dr. Jerome Kim (Director-General, International Vaccine Institute)

9:30am // TALK - VACCINE HESITANCY

                   Dr. Heidi Larson (Founding Director of the Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine

                                                 Former Director of Global Immunization Communication at UNICEF

                                                 Professor of Anthropology, Risk and Decision Science

                                                 Author of STUCK: How Vaccine Rumors Start – and Why They Don’t Go Away)

10:00am // Corporate Presentation - FSD BioSciences (HUGE)

10:20am // Corporate Presentation - Maxwell Biosciences

10:40am // Corporate Presentation - CytoAgents

11:00am // TALK - REVIEW OF EVIDENCE REGARDING IVERMECTIN FOR THE TREATMENT OF COVID-19

                     Dr. Paul Marik (Chief, Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School) 

11:30am // Corporate Presentation - Tactical Therapeutics

11:50am // Corporate Presentation - Cytocom

12:10pm // Corporate Presentation - SciTech Development

12:30pm // TALK - PARTNERING FOR VALUE: TECHNOLOGY TRANSFER AT NIAID

                     Dr. Wade Green (Team Lead, Technology Transfer & Intellectual Property Office (TTIPO) 

                                                  National Institute of Allergy and Infectious Diseases (NIAID)

1:00pm // LUNCH PANEL - T-CELL THERAPY PANEL

                                                 Moderator: William Werkmeister (Partner, OIP Partners, /Advisory Board, National Foundation for Cancer Research) 

                                                 Panelist: Alfred Slanetz (CEO, Geneius Biotech, Former CEO, Bluebird Bio, Former Head Product Development, Genetech)

                                                 Panelist: Wayne Froland (Former Director Complex Manufacturing, Merck)

                                                 Panelist: Phil Friedland (Professor Medicine, Hematology and Medical Oncology, Mt. Sinai)

1:40pm // Corporate Presentation - Elpis Biopharmaceuticals

2:00pm // Corporate Presentation - Cumberland Emerging Technologies

2:20pm // Corporate Presentation - MAIA Biotechnology

2:40pm // Corporate Presentation - ODS Medical

3:00pm // Corporate Presentation - pHLIP

3:20pm // Corporate Presentation - Novian Health

3:40pm // Corporate Presentation - TAE Life Sciences

4:00pm // Corporate Presentation - Qu Biologics

4:20pm // Corporate Presentation - Rafael Farma

4:40pm // Corporate Presentation - NaNotics

5:00pm // FIRESIDE CHAT - THERAPEUTIC DEVICES

                   Moderator: William Werkmeister, Partner, OIP and Advisory Board, NFCR
                                        Amir Jafri, CEO and Founder, Immunicom | Former Director of M&A and R&D, Cardinal Health
                                        Dr. Augusto Bastidas, Founder, International Medical Management Group

5:30pm // CLOSING REMARKS

WEDNESDAY, MARCH 31, 2021

All Times are EST Time Zone

8:50am // OPENING REMARKS 

9:00am // TALK - THE NATIONAL CANCER INSTITUTE AS A TECHNOLOGY DEVELOPMENT AND COMMERCIALIZATION PARTNER: IMPACTING PIPELINES AND BOTTOM LINES

                   Steven Ferguson (Deputy Director and Chair, Licensing and Entrepreneurship | NIH Office of Technology Transfer)
                   Dr. Michael Salgaller (Supervisor, Invention Development and Marketing Unit, Technology Transfer Center | National Cancer Institute | National
                    Institutes of Health)

9:30am // Corporate Presentation - PinotBio

9:50am // Corporate Presentation - Oncolize

10:10am // Corporate Presentation - SciTech Development

10:30am // Corporate Presentation - Zilico Limited

10:50am // Corporate Presentation - SignalChem Life Sciences

11:10am // Corporate Presentation - Innova Therapeutics

11:30am // Corporate Presentation - EarlyDiagnostics

11:50am // Corporate Presentation - Tactical Therapeutics

12:10pm // Featured Corporation Presentation - Apricity Health

                      Dr. Jim Allison (2018 Nobel Laureate | Partner, Apricity)                                                                 

                      Dr. Lynda Chin (CEO Apricity | Founder, Department of Genomic Medicine, MD Anderson Cancer Center)                                                 
                      Dr. Pam Sharma (Partner, Apricity | Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, MD Anderson)

                      Dr. Keith Flaherty (Partner, Apricity | Director of Developmental Therapeutics at the Massachusetts General Hospital Cancer Center | Founder, LOXO
                      Oncology)

12:40pm // Corporate Presentation - Indi Molecular

1:00pm // Corporate Presentation - Thrive Bioscience

1:20pm // Corporate Presentation - Genomic Expression

1:40pm // Corporate Presentation - Illumacell

2:00pm // Corporate Presentation - International Medical Management Group

2:20pm // Corporate Presentation - Saccharo

2:40pm // Corporate Presentation - Nuview Life Sciences

3:00pm // Corporate Presentation - Alyra Therapeutics

3:20pm // Corporate Presentation - OncoXome

3:40pm // Corporate Presentation - Tradewind BioScience

4:00pm // Corporate Presentation - Tvardi Therapeutics

4:20pm // Corporate Presentation - Adanate

4:40pm // TALK - THE HISTORY AND FUTURE OF GENOMIC TESTING

                    Priti Hegde (CSO, Foundation Medicine)

5:10pm // CLOSING REMARKS

THURSDAY, APRIL 1, 2021

All Times are EST Time Zone

8:50am // OPENING REMARKS 

9:00am // TALK - THE EXPONENTIAL INCORPORATION OF LIQUID BIOPSY IN CANCER THERAPY

                   Brian Leyland-Jones (Former Director of Emory and McGill Cancer Centers | CMO National Foundation for Cancer Research
                                                         Chief Science Officer, The Darwin Foundation)

9:30am // Corporate Presentation - Impact Therapeutics

9:50am // Corporate Presentation - LeadInvent Pharma

10:10am // Corporate Presentation - Jubilant Life Sciences

10:30am // Corporate Presentation - Lightpoint Medical 

10:50am // Corporate Presentation - LifeBridge 10000

11:10am // Corporate Presentation - Creatv MicroTech

11:30am // Corporate Presentation - AHEAD Medicine

11:50am // Corporate Presentation - Onconova Therapeutics

12:10pm // WOMEN IN CANCER PANEL
                     Moderator: Dr. Lynda Chin, Founder, Department of Genomic Medicine, MD Anderson Cancer Center
                     Panelist: Pam Sharma, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, MD Anderson
                     Panelist: Sung Poblete, CEO, Stand Up to Cancer

                     Panelist: Gitte Peterson, CEO of Genomic Expression

12:40om // Corporate Presentation - Promaxo 
1:00pm // Corporate Presentation - Ovensa

1:20pm // Corporate Presentation - Kineta

1:40pm // Corporate Presentation -Travera

2:00pm // Corporate Presentation - EhmetHealth

2:20pm // Corporate Presentation - ENB Therapeutics

2:40pm // Corporate Presentation - Summit Biomedical Imaging

3:00pm // Corporate Presentation - Qrono

3:20pm // Corporate Presentation - Geneius Biotechnology

3:40pm // FIRESIDE CHAT
                   Moderator: William Werkmeister

                   Participant: Brian Leyland-Jones (Former Director of Emory and McGill Cancer Centers | CMO National Foundation for Cancer Research                                                                   Chief Science Officer, The Darwin Foundation)

                   Participant: Ralph Parchment (Managing Director, DCTD Program in Pharmacodynamic Biomarkers, NCI)

4:10pm // CLOSING REMARKS